MPO and systemic lupus erythematosus: The remaining patients hadnonvasculitic inflammatory conditions such as systemic lupus erythematosus andinflammatory bowel disease.20 The 1999 International Consensus on ANCA testing dictates that indirect IFshould be used as a screening tool and confirmed by ELISA for MPO and PR-3.21